, , , e.a.

Phase II Clinical Development of New Drugs

Paperback Engels 2018 9789811350740
€ 144,99
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.

Specificaties

ISBN13:9789811350740
Taal:Engels
Bindwijze:paperback
Uitgever:Springer Nature Singapore

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

Chapter 1 Introduction.- Chapter 2 Concept of Alpha.- Chapter 3 Confirmation and Exploration.- Chapter 4 Design a Proof of Concept (PoC) Trial.- Chapter 5 Design of Dose-Ranging Trials.- Chapter 6 Combining PoC and Dose Ranging Trials.- Chapter 7 Risks of Inconclusiveness.- Chapter 8 Analysis of a PoC Study.- Chapter 9 Data Analysis for Dose-Ranging Trials with Continuous Outcome.- Chapter 10 Data Analysis of Dose-Ranging Trials for Binary Outcomes.- Chapter 11 Bayesian Methods.- Chapter 12 Overview of Phase III Clinical Trials.

Managementboek Top 100

€ 144,99
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Phase II Clinical Development of New Drugs